25 XP   0   0   10

Addex Therapeutics Ltd
Buy, Hold or Sell?

Let's analyse Addex Therapeutics Ltd together

PenkeI guess you are interested in Addex Therapeutics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Addex Therapeutics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Addex Therapeutics Ltd

I send you an email if I find something interesting about Addex Therapeutics Ltd.

Quick analysis of Addex Therapeutics Ltd (30 sec.)










What can you expect buying and holding a share of Addex Therapeutics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
$0.09
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$0.06
Expected worth in 1 year
$-0.07
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
$-0.03
Return On Investment
-0.3%

For what price can you sell your share?

Current Price per Share
$12.35
Expected price per share
$8.73 - $13.40
How sure are you?
50%

1. Valuation of Addex Therapeutics Ltd (5 min.)




Live pricePrice per Share (EOD)

$12.35

Intrinsic Value Per Share

$0.92 - $2.01

Total Value Per Share

$0.98 - $2.07

2. Growth of Addex Therapeutics Ltd (5 min.)




Is Addex Therapeutics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$4.3m$12.3m-$7m-134.6%

How much money is Addex Therapeutics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3.1m-$5.9m$2.8m90.1%
Net Profit Margin-579.9%-2,127.4%--

How much money comes from the company's main activities?

3. Financial Health of Addex Therapeutics Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#772 / 1031

Most Revenue
#535 / 1031

Most Profit
#385 / 1031

Most Efficient
#773 / 1031

What can you expect buying and holding a share of Addex Therapeutics Ltd? (5 min.)

Welcome investor! Addex Therapeutics Ltd's management wants to use your money to grow the business. In return you get a share of Addex Therapeutics Ltd.

What can you expect buying and holding a share of Addex Therapeutics Ltd?

First you should know what it really means to hold a share of Addex Therapeutics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Addex Therapeutics Ltd is $12.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Addex Therapeutics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Addex Therapeutics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.06. Based on the TTM, the Book Value Change Per Share is $-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Addex Therapeutics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.04-0.3%-0.05-0.4%-0.15-1.3%-0.16-1.3%-0.11-0.9%
Usd Book Value Change Per Share-0.04-0.3%-0.03-0.3%-0.06-0.5%-0.08-0.6%-0.01-0.1%
Usd Dividend Per Share0.000.0%0.020.2%0.000.0%0.010.0%0.000.0%
Usd Total Gains Per Share-0.04-0.3%-0.01-0.1%-0.06-0.5%-0.07-0.6%-0.01-0.1%
Usd Price Per Share0.38-0.62-3.33-4.29-2.15-
Price to Earnings Ratio-2.57--3.22--5.53--9.34--4.67-
Price-to-Total Gains Ratio-10.29--150.21--10.78--71.20--71.20-
Price to Book Ratio6.82-7.97-8.80-8.98-4.49-
Price-to-Total Gains Ratio-10.29--150.21--10.78--71.20--71.20-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.35
Number of shares80
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share-0.03-0.08
Usd Total Gains Per Share-0.01-0.07
Gains per Quarter (80 shares)-0.67-5.99
Gains per Year (80 shares)-2.67-23.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
18-10-132-26-34
215-20-163-51-58
323-31-195-77-82
430-41-226-102-106
538-51-258-128-130
645-61-2810-153-154
753-71-3111-179-178
860-82-3413-205-202
968-92-3714-230-226
1075-102-4016-256-250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.038.00.05.0%2.043.00.04.4%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%9.031.00.022.5%11.034.00.024.4%
Dividend per Share3.00.01.075.0%4.00.08.033.3%4.00.016.020.0%4.00.036.010.0%4.00.041.08.9%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%9.031.00.022.5%11.034.00.024.4%

Fundamentals of Addex Therapeutics Ltd

About Addex Therapeutics Ltd

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for pain, anxiety, and addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot"Marie"Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Fundamental data was last updated by Penke on 2024-03-20 08:54:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Addex Therapeutics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Addex Therapeutics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Addex Therapeutics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -798.5% means that $-7.99 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Addex Therapeutics Ltd:

  • The MRQ is -798.5%. The company is making a huge loss. -2
  • The TTM is -579.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-798.5%TTM-579.9%-218.7%
TTM-579.9%YOY-2,127.4%+1,547.5%
TTM-579.9%5Y-1,389.4%+809.5%
5Y-1,389.4%10Y-1,039.4%-350.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-798.5%-171.8%-626.7%
TTM-579.9%-205.8%-374.1%
YOY-2,127.4%-262.1%-1,865.3%
5Y-1,389.4%-455.6%-933.8%
10Y-1,039.4%-589.0%-450.4%
1.1.2. Return on Assets

Shows how efficient Addex Therapeutics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Addex Therapeutics Ltd to the Biotechnology industry mean.
  • -42.6% Return on Assets means that Addex Therapeutics Ltd generated $-0.43 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Addex Therapeutics Ltd:

  • The MRQ is -42.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -37.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-42.6%TTM-37.4%-5.3%
TTM-37.4%YOY-37.4%+0.0%
TTM-37.4%5Y-22.4%-15.0%
5Y-22.4%10Y-21.6%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.6%-12.5%-30.1%
TTM-37.4%-12.2%-25.2%
YOY-37.4%-11.2%-26.2%
5Y-22.4%-13.4%-9.0%
10Y-21.6%-14.7%-6.9%
1.1.3. Return on Equity

Shows how efficient Addex Therapeutics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Addex Therapeutics Ltd to the Biotechnology industry mean.
  • -66.3% Return on Equity means Addex Therapeutics Ltd generated $-0.66 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Addex Therapeutics Ltd:

  • The MRQ is -66.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -60.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-66.3%TTM-60.9%-5.5%
TTM-60.9%YOY-57.0%-3.9%
TTM-60.9%5Y-33.0%-27.9%
5Y-33.0%10Y-33.4%+0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-66.3%-15.8%-50.5%
TTM-60.9%-15.7%-45.2%
YOY-57.0%-13.9%-43.1%
5Y-33.0%-18.3%-14.7%
10Y-33.4%-19.2%-14.2%

1.2. Operating Efficiency of Addex Therapeutics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Addex Therapeutics Ltd is operating .

  • Measures how much profit Addex Therapeutics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Addex Therapeutics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -805.2% means the company generated $-8.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Addex Therapeutics Ltd:

  • The MRQ is -805.2%. The company is operating very inefficient. -2
  • The TTM is -569.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-805.2%TTM-569.1%-236.1%
TTM-569.1%YOY-2,097.6%+1,528.5%
TTM-569.1%5Y-1,338.6%+769.5%
5Y-1,338.6%10Y-952.0%-386.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-805.2%-299.1%-506.1%
TTM-569.1%-210.1%-359.0%
YOY-2,097.6%-279.7%-1,817.9%
5Y-1,338.6%-459.9%-878.7%
10Y-952.0%-596.9%-355.1%
1.2.2. Operating Ratio

Measures how efficient Addex Therapeutics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 9.09 means that the operating costs are $9.09 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Addex Therapeutics Ltd:

  • The MRQ is 9.094. The company is inefficient in keeping operating costs low. -1
  • The TTM is 14.471. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ9.094TTM14.471-5.377
TTM14.471YOY21.976-7.505
TTM14.4715Y16.262-1.791
5Y16.26210Y12.032+4.230
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.0942.861+6.233
TTM14.4713.193+11.278
YOY21.9763.615+18.361
5Y16.2625.560+10.702
10Y12.0327.396+4.636

1.3. Liquidity of Addex Therapeutics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Addex Therapeutics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.97 means the company has $2.97 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Addex Therapeutics Ltd:

  • The MRQ is 2.974. The company is able to pay all its short-term debts. +1
  • The TTM is 2.683. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.974TTM2.683+0.291
TTM2.683YOY3.752-1.069
TTM2.6835Y5.887-3.205
5Y5.88710Y5.307+0.581
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9743.986-1.012
TTM2.6834.440-1.757
YOY3.7525.552-1.800
5Y5.8876.158-0.271
10Y5.3076.492-1.185
1.3.2. Quick Ratio

Measures if Addex Therapeutics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Addex Therapeutics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 2.66 means the company can pay off $2.66 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Addex Therapeutics Ltd:

  • The MRQ is 2.656. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.423. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.656TTM2.423+0.233
TTM2.423YOY3.422-0.999
TTM2.4235Y5.348-2.925
5Y5.34810Y4.944+0.404
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6563.638-0.982
TTM2.4234.168-1.745
YOY3.4225.515-2.093
5Y5.3486.012-0.664
10Y4.9446.209-1.265

1.4. Solvency of Addex Therapeutics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Addex Therapeutics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Addex Therapeutics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.36 means that Addex Therapeutics Ltd assets are financed with 35.7% credit (debt) and the remaining percentage (100% - 35.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Addex Therapeutics Ltd:

  • The MRQ is 0.357. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.381. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.357TTM0.381-0.024
TTM0.381YOY0.316+0.065
TTM0.3815Y0.258+0.124
5Y0.25810Y0.329-0.072
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3570.335+0.022
TTM0.3810.330+0.051
YOY0.3160.267+0.049
5Y0.2580.367-0.109
10Y0.3290.378-0.049
1.4.2. Debt to Equity Ratio

Measures if Addex Therapeutics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Addex Therapeutics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 55.6% means that company has $0.56 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Addex Therapeutics Ltd:

  • The MRQ is 0.556. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.626. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.556TTM0.626-0.069
TTM0.626YOY0.474+0.152
TTM0.6265Y0.371+0.255
5Y0.37110Y0.531-0.160
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5560.376+0.180
TTM0.6260.398+0.228
YOY0.4740.334+0.140
5Y0.3710.429-0.058
10Y0.5310.476+0.055

2. Market Valuation of Addex Therapeutics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Addex Therapeutics Ltd generates.

  • Above 15 is considered overpriced but always compare Addex Therapeutics Ltd to the Biotechnology industry mean.
  • A PE ratio of -2.57 means the investor is paying $-2.57 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Addex Therapeutics Ltd:

  • The EOD is -82.529. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.568. Based on the earnings, the company is expensive. -2
  • The TTM is -3.220. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-82.529MRQ-2.568-79.961
MRQ-2.568TTM-3.220+0.652
TTM-3.220YOY-5.532+2.312
TTM-3.2205Y-9.343+6.124
5Y-9.34310Y-4.672-4.672
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-82.529-2.643-79.886
MRQ-2.568-2.418-0.150
TTM-3.220-2.742-0.478
YOY-5.532-4.123-1.409
5Y-9.343-6.257-3.086
10Y-4.672-6.478+1.806
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Addex Therapeutics Ltd:

  • The EOD is -95.873. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.983. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.567. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-95.873MRQ-2.983-92.890
MRQ-2.983TTM-3.567+0.583
TTM-3.567YOY-7.638+4.071
TTM-3.5675Y97.968-101.535
5Y97.96810Y48.984+48.984
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-95.873-3.244-92.629
MRQ-2.983-2.939-0.044
TTM-3.567-3.478-0.089
YOY-7.638-5.592-2.046
5Y97.968-8.473+106.441
10Y48.984-8.881+57.865
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Addex Therapeutics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.82 means the investor is paying $6.82 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Addex Therapeutics Ltd:

  • The EOD is 219.027. Based on the equity, the company is expensive. -2
  • The MRQ is 6.816. Based on the equity, the company is overpriced. -1
  • The TTM is 7.970. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD219.027MRQ6.816+212.211
MRQ6.816TTM7.970-1.154
TTM7.970YOY8.795-0.825
TTM7.9705Y8.985-1.015
5Y8.98510Y4.492+4.492
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD219.0272.124+216.903
MRQ6.8162.041+4.775
TTM7.9702.118+5.852
YOY8.7952.915+5.880
5Y8.9853.682+5.303
10Y4.4924.114+0.378
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Addex Therapeutics Ltd.

3.1. Institutions holding Addex Therapeutics Ltd

Institutions are holding 18.486% of the shares of Addex Therapeutics Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Armistice Capital, LLC4.05830.003643000430000
2023-12-31NEA Management Company, LLC0.84940.0204900090000
Total 4.90770.02452000+52000+100.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Addex Therapeutics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.037-0.032-15%-0.062+66%-0.080+114%-0.009-76%
Book Value Per Share--0.0560.080-29%0.325-83%0.922-94%0.696-92%
Current Ratio--2.9742.683+11%3.752-21%5.887-49%5.307-44%
Debt To Asset Ratio--0.3570.381-6%0.316+13%0.258+39%0.329+8%
Debt To Equity Ratio--0.5560.626-11%0.474+17%0.371+50%0.531+5%
Dividend Per Share---0.024-100%0.002-100%0.005-100%0.003-100%
Eps---0.037-0.049+32%-0.155+313%-0.162+332%-0.111+196%
Free Cash Flow Per Share---0.032-0.044+37%-0.117+265%-0.090+179%-0.071+121%
Free Cash Flow To Equity Per Share---0.035-0.024-32%-0.035+1%-0.057+64%0.018-295%
Gross Profit Margin--1.0001.0000%1.0000%1.0040%1.067-6%
Intrinsic Value_10Y_max--2.014--------
Intrinsic Value_10Y_min--0.920--------
Intrinsic Value_1Y_max---0.214--------
Intrinsic Value_1Y_min---0.263--------
Intrinsic Value_3Y_max---0.327--------
Intrinsic Value_3Y_min---0.488--------
Intrinsic Value_5Y_max---0.057--------
Intrinsic Value_5Y_min---0.379--------
Market Cap13085689.500-127%29698139.84840298310.125-26%123139476.970-76%136602402.360-78%68301201.180-57%
Net Profit Margin---7.985-5.799-27%-21.274+166%-13.894+74%-10.394+30%
Operating Margin---8.052-5.691-29%-20.976+160%-13.386+66%-9.520+18%
Operating Ratio--9.09414.471-37%21.976-59%16.262-44%12.032-24%
Pb Ratio219.027+97%6.8167.970-14%8.795-23%8.985-24%4.492+52%
Pe Ratio-82.529-3114%-2.568-3.220+25%-5.532+115%-9.343+264%-4.672+82%
Price Per Share12.350+97%0.3840.620-38%3.330-88%4.293-91%2.146-82%
Price To Free Cash Flow Ratio-95.873-3114%-2.983-3.567+20%-7.638+156%97.968-103%48.984-106%
Price To Total Gains Ratio-330.550-3114%-10.286-150.212+1360%-10.780+5%-71.196+592%-71.196+592%
Quick Ratio--2.6562.423+10%3.422-22%5.348-50%4.944-46%
Return On Assets---0.426-0.374-12%-0.374-12%-0.224-48%-0.216-49%
Return On Equity---0.663-0.609-8%-0.570-14%-0.330-50%-0.334-50%
Total Gains Per Share---0.037-0.008-78%-0.061+62%-0.075+101%-0.006-83%
Usd Book Value--4357417.3455262425.420-17%12345185.996-65%19358773.571-77%14033970.188-69%
Usd Book Value Change Per Share---0.037-0.032-15%-0.062+66%-0.080+114%-0.009-76%
Usd Book Value Per Share--0.0560.080-29%0.325-83%0.922-94%0.696-92%
Usd Dividend Per Share---0.024-100%0.002-100%0.005-100%0.003-100%
Usd Eps---0.037-0.049+32%-0.155+313%-0.162+332%-0.111+196%
Usd Free Cash Flow---2488673.684-2885154.380+16%-4511409.763+81%-3150040.230+27%-1828329.289-27%
Usd Free Cash Flow Per Share---0.032-0.044+37%-0.117+265%-0.090+179%-0.071+121%
Usd Free Cash Flow To Equity Per Share---0.035-0.024-32%-0.035+1%-0.057+64%0.018-295%
Usd Market Cap13085689.500-127%29698139.84840298310.125-26%123139476.970-76%136602402.360-78%68301201.180-57%
Usd Price Per Share12.350+97%0.3840.620-38%3.330-88%4.293-91%2.146-82%
Usd Profit---2891077.229-3134858.835+8%-5958910.877+106%-4023490.065+39%-2351897.821-19%
Usd Revenue--362046.645566692.320-36%339003.708+7%716818.730-49%618485.986-41%
Usd Total Gains Per Share---0.037-0.008-78%-0.061+62%-0.075+101%-0.006-83%
 EOD+3 -5MRQTTM+14 -21YOY+19 -165Y+19 -1710Y+10 -26

4.2. Fundamental Score

Let's check the fundamental score of Addex Therapeutics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-82.529
Price to Book Ratio (EOD)Between0-1219.027
Net Profit Margin (MRQ)Greater than0-7.985
Operating Margin (MRQ)Greater than0-8.052
Quick Ratio (MRQ)Greater than12.656
Current Ratio (MRQ)Greater than12.974
Debt to Asset Ratio (MRQ)Less than10.357
Debt to Equity Ratio (MRQ)Less than10.556
Return on Equity (MRQ)Greater than0.15-0.663
Return on Assets (MRQ)Greater than0.05-0.426
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Addex Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.145
Ma 20Greater thanMa 5011.081
Ma 50Greater thanMa 10010.389
Ma 100Greater thanMa 2008.166
OpenGreater thanClose12.350
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CHF. All numbers in thousands.

Summary
Total Assets6,138
Total Liabilities2,194
Total Stockholder Equity3,944
 As reported
Total Liabilities 2,194
Total Stockholder Equity+ 3,944
Total Assets = 6,138

Assets

Total Assets6,138
Total Current Assets5,743
Long-term Assets395
Total Current Assets
Cash And Cash Equivalents 4,754
Short-term Investments 0
Net Receivables 373
Other Current Assets 615
Total Current Assets  (as reported)5,743
Total Current Assets  (calculated)5,743
+/-0
Long-term Assets
Property Plant Equipment 341
Long-term Assets Other 54
Long-term Assets  (as reported)395
Long-term Assets  (calculated)395
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,931
Long-term Liabilities263
Total Stockholder Equity3,944
Total Current Liabilities
Short-term Debt 206
Accounts payable 390
Other Current Liabilities 1,335
Total Current Liabilities  (as reported)1,931
Total Current Liabilities  (calculated)1,931
+/-0
Long-term Liabilities
Capital Lease Obligations 323
Long-term Liabilities  (as reported)263
Long-term Liabilities  (calculated)323
+/- 61
Total Stockholder Equity
Common Stock1,425
Retained Earnings -357,561
Accumulated Other Comprehensive Income 31,673
Other Stockholders Equity 328,408
Total Stockholder Equity (as reported)3,944
Total Stockholder Equity (calculated)3,944
+/-0
Other
Capital Stock1,425
Cash and Short Term Investments 4,755
Common Stock Shares Outstanding 77,279
Liabilities and Stockholders Equity 6,138
Net Debt -4,431
Net Invested Capital 3,944
Net Working Capital 3,812
Property Plant and Equipment Gross 4,583
Short Long Term Debt Total 323



Balance Sheet

Currency in CHF. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302011-12-312011-06-302010-12-312010-06-302009-12-31
> Total Assets 
88,553
68,158
74,284
59,544
43,616
28,141
21,736
21,736
9,449
9,449
5,880
5,880
4,411
4,411
3,999
3,999
3,900
3,900
2,890
2,890
2,601
2,601
1,683
1,683
3,847
3,847
3,063
3,063
44,870
44,870
42,214
42,214
37,969
37,969
0
33,029
33,029
23,147
19,646
20,182
26,875
21,532
18,060
22,542
17,681
11,382
12,242
8,282
7,295
8,998
6,138
6,1388,9987,2958,28212,24211,38217,68122,54218,06021,53226,87520,18219,64623,14733,02933,029037,96937,96942,21442,21444,87044,8703,0633,0633,8473,8471,6831,6832,6012,6012,8902,8903,9003,9003,9993,9994,4114,4115,8805,8809,4499,44921,73621,73628,14143,61659,54474,28468,15888,553
   > Total Current Assets 
78,399
59,609
66,495
53,068
38,068
22,429
17,021
17,021
6,245
6,245
3,901
3,901
2,481
2,481
2,139
2,139
3,803
3,803
2,783
2,783
2,564
2,564
1,659
1,659
3,836
3,836
3,053
3,053
44,859
44,859
42,151
42,151
41,670
37,496
32,389
32,389
32,389
22,692
19,248
19,490
26,266
21,000
17,436
21,942
17,162
10,946
11,701
7,829
6,915
8,692
5,743
5,7438,6926,9157,82911,70110,94617,16221,94217,43621,00026,26619,49019,24822,69232,38932,38932,38937,49641,67042,15142,15144,85944,8593,0533,0533,8363,8361,6591,6592,5642,5642,7832,7833,8033,8032,1392,1392,4812,4813,9013,9016,2456,24517,02117,02122,42938,06853,06866,49559,60978,399
       Cash And Cash Equivalents 
76,560
56,687
63,797
50,230
36,065
20,237
15,257
15,257
4,479
4,479
2,913
2,913
2,094
2,094
1,980
1,980
3,579
3,579
2,634
2,634
2,255
2,255
1,416
1,416
3,574
3,574
2,579
2,591
43,573
43,573
41,670
41,670
36,748
36,748
0
31,537
31,537
20,671
17,813
18,695
25,220
18,108
15,486
20,485
14,888
8,813
10,423
6,957
5,595
7,169
4,754
4,7547,1695,5956,95710,4238,81314,88820,48515,48618,10825,22018,69517,81320,67131,53731,537036,74836,74841,67041,67043,57343,5732,5912,5793,5743,5741,4161,4162,2552,2552,6342,6343,5793,5791,9801,9802,0942,0942,9132,9134,4794,47915,25715,25720,23736,06550,23063,79756,68776,560
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
6
6
0
14
14
54
66
65
10
38
28
17
9
4
3
3
4
17
0
0174334917283810656654141406688000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
982
0
0
0
812
0
0
0
92
0
0
0
132
0
0
0
221
0
0
0
304
0
966
273
273
286
286
118
118
118
104
76
68
184
1,228
582
324
435
410
457
598
431
502
373
3735024315984574104353245821,22818468761041181181182862862732739660304000221000132000920008120009820000000
       Other Current Assets 
1,838
2,922
2,698
2,838
2,003
2,192
0
781
0
1,767
0
176
0
387
0
68
0
224
0
17
0
309
0
21
0
261
0
159
0
319
0
199
0
455
0
14
720
1,863
1,293
661
853
1,626
1,340
1,115
1,831
1,720
818
270
884
1,003
615
6151,0038842708181,7201,8311,1151,3401,6268536611,2931,8637201404550199031901590261021030901702240680387017601,767078102,1922,0032,8382,6982,9221,838
   > Long-term Assets 
10,155
8,549
7,789
6,476
5,548
5,712
2,187
4,715
589
3,204
232
1,979
107
1,930
58
1,860
21
96
32
107
31
37
17
24
5
12
3
10
4
11
9
63
0
473
0
640
640
455
398
692
608
532
624
600
519
436
541
453
380
307
395
39530738045354143651960062453260869239845564064004730639114103125241737311073296211,860581,9301071,9792323,2045894,7152,1875,7125,5486,4767,7898,54910,155
       Property Plant Equipment 
9,568
8,021
6,668
5,411
3,964
2,702
2,090
2,090
515
515
180
180
75
75
45
45
21
21
32
32
31
31
17
17
5
5
3
3
4
4
9
9
419
419
571
571
571
387
330
633
549
472
566
542
461
378
481
399
325
253
341
341253325399481378461542566472549633330387571571571419419994433551717313132322121454575751801805155152,0902,0902,7023,9645,4116,6688,0219,568
       Intangible Assets 
182
125
84
55
32
0
98
98
74
74
53
53
32
32
13
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,801
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000018,801000000000000000000000131332325353747498980325584125182
       Long-term Assets Other 
405
404
1,037
1,010
1,551
2,886
-2,187
2,528
-589
2,615
-232
1,747
-107
1,823
-58
1,802
-21
75
-32
75
-31
7
-17
7
-5
7
-3
7
-4
7
-9
54
0
54
0
69
69
69
68
59
59
-472
58
58
58
58
60
54
54
54
54
545454546058585858-472595968696969054054-97-47-37-57-177-3175-3275-211,802-581,823-1071,747-2322,615-5892,528-2,1872,8861,5511,0101,037404405
> Total Liabilities 
10,973
7,718
9,870
9,730
9,780
8,665
4,656
5,445
6,566
6,566
2,363
2,854
1,814
2,361
1,509
1,654
978
1,164
1,030
1,225
1,037
1,421
1,250
1,464
1,240
1,468
1,477
1,721
2,353
2,597
2,334
2,973
5,696
5,696
0
7,505
7,505
4,346
3,902
5,572
6,176
5,109
4,719
5,611
4,726
4,520
4,290
3,369
3,223
2,872
2,194
2,1942,8723,2233,3694,2904,5204,7265,6114,7195,1096,1765,5723,9024,3467,5057,50505,6965,6962,9732,3342,5972,3531,7211,4771,4681,2401,4641,2501,4211,0371,2251,0301,1649781,6541,5092,3611,8142,8542,3636,5666,5665,4454,6568,6659,7809,7309,8707,71810,973
   > Total Current Liabilities 
10,890
7,441
9,277
8,944
8,728
7,932
4,656
4,656
6,566
6,566
2,363
2,363
1,814
1,814
1,509
1,509
978
978
1,030
1,030
1,037
1,037
1,250
1,250
1,240
1,240
1,477
1,477
2,353
2,353
2,334
2,334
4,405
4,405
5,681
5,681
5,681
2,809
2,217
3,621
4,611
3,684
3,271
4,135
3,972
4,296
4,129
3,282
3,187
2,714
1,931
1,9312,7143,1873,2824,1294,2963,9724,1353,2713,6844,6113,6212,2172,8095,6815,6815,6814,4054,4052,3342,3342,3532,3531,4771,4771,2401,2401,2501,2501,0371,0371,0301,0309789781,5091,5091,8141,8142,3632,3636,5666,5664,6564,6567,9328,7288,9449,2777,44110,890
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
0
0
0
65
0
0
0
0
0
44
0
11
0
34
0
15
0
281
0
373
373
290
215
309
303
259
291
288
292
243
286
286
223
200
206
2062002232862862432922882912593033092152903733730281015034011044000006500012000000000000000
       Accounts payable 
0
0
0
0
0
0
710
710
1,634
1,634
606
606
836
836
647
647
152
152
171
171
346
346
670
670
262
262
383
383
1,003
1,003
1,149
1,149
1,894
1,894
2,216
2,216
2,216
958
433
984
2,229
1,209
1,157
1,787
1,422
1,819
2,995
1,277
1,076
1,114
390
3901,1141,0761,2772,9951,8191,4221,7871,1571,2092,2299844339582,2162,2162,2161,8941,8941,1491,1491,0031,0033833832622626706703463461711711521526476478368366066061,6341,634710710000000
       Other Current Liabilities 
10,890
7,441
9,277
8,944
8,728
7,932
3,947
3,947
4,932
4,932
1,757
1,757
978
978
862
836
825
825
859
794
691
691
580
580
978
659
1,094
644
1,350
964
1,185
957
0
2,042
1,111
1,111
1,980
1,341
1,418
1,508
2,066
2,216
1,712
2,060
2,259
2,234
848
1,719
1,889
1,399
1,335
1,3351,3991,8891,7198482,2342,2592,0601,7122,2162,0661,5081,4181,3411,9801,1111,1112,04209571,1859641,3506441,0946599785805806916917948598258258368629789781,7571,7574,9324,9323,9473,9477,9328,7288,9449,2777,44110,890
   > Long-term Liabilities 
83
278
592
785
1,052
733
0
789
0
0
0
490
0
547
0
145
0
187
0
196
0
384
0
214
0
227
0
244
0
243
0
639
0
1,291
0
1,824
1,824
1,537
1,686
1,951
1,564
1,425
1,448
1,476
754
223
161
87
36
158
263
26315836871612237541,4761,4481,4251,5641,9511,6861,5371,8241,82401,2910639024302440227021403840196018701450547049000078907331,05278559227883
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
114
0
177
104
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001041770114000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
639
651
1,177
1,177
1,647
1,647
1,325
1,462
1,632
1,693
1,377
1,263
1,218
1,282
633
129
0
0
0
126
0
01260001296331,2821,2181,2631,3771,6931,6321,4621,3251,6471,6471,1771,177651639000000000000000000000000000000
> Total Stockholder Equity
77,581
60,440
64,414
49,814
33,836
19,475
-248,548
16,291
-262,998
2,883
-261,839
3,026
-262,810
2,050
-263,614
2,346
-264,922
2,736
-266,292
1,664
-266,022
1,180
-267,687
219
-267,544
2,379
-269,037
1,343
-253,504
42,274
-257,503
39,241
32,273
32,273
0
25,524
25,524
18,801
15,744
14,610
20,699
16,423
13,341
16,931
12,955
6,862
7,952
4,913
4,071
6,126
3,944
3,9446,1264,0714,9137,9526,86212,95516,93113,34116,42320,69914,61015,74418,80125,52425,524032,27332,27339,241-257,50342,274-253,5041,343-269,0372,379-267,544219-267,6871,180-266,0221,664-266,2922,736-264,9222,346-263,6142,050-262,8103,026-261,8392,883-262,99816,291-248,54819,47533,83649,81464,41460,44077,581
   Common Stock
5,741
5,741
6,334
7,705
7,705
7,712
9,003
8,634
9,003
8,637
10,174
9,843
10,174
9,844
10,174
9,985
11,700
10,998
11,700
11,025
13,455
11,371
13,455
11,564
15,385
13,251
15,385
13,420
28,564
26,372
28,564
28,564
32,849
32,849
32,849
32,849
32,849
32,849
32,849
32,849
39,749
49,273
49,273
49,273
65,273
65,273
653
1,153
1,153
1,365
1,425
1,4251,3651,1531,15365365,27365,27349,27349,27349,27339,74932,84932,84932,84932,84932,84932,84932,84932,84928,56428,56426,37228,56413,42015,38513,25115,38511,56413,45511,37113,45511,02511,70010,99811,7009,98510,1749,84410,1749,84310,1748,6379,0038,6349,0037,7127,7057,7056,3345,7415,741
   Retained Earnings -357,561-354,944-352,269-349,862-346,210-342,103-334,882-329,058-324,634-321,036-316,346-313,706-311,581-308,268-300,847-300,847-300,847-293,607-293,607-286,067-286,067-282,068-282,068-284,422-284,422-282,929-282,929-281,141-281,141-279,477-279,477-277,992-277,992-276,621-276,621-273,788-273,788-272,983-272,983-272,013-272,013-272,001-272,001-256,089-257,551-243,828-229,070-212,756-197,929-181,546-164,284
   Accumulated Other Comprehensive Income 
-13,840
0
-15,373
0
-17,462
0
0
6,031
0
8,639
0
5,506
0
5,504
0
6,128
0
6,285
0
6,553
0
6,488
0
6,758
0
7,313
0
7,547
0
11,835
0
10,266
0
6,573
0
7,147
7,147
7,824
14,471
8,579
8,905
15,434
15,898
24,438
26,507
27,646
26,698
25,768
26,169
32,063
31,673
31,67332,06326,16925,76826,69827,64626,50724,43815,89815,4348,9058,57914,4717,8247,1477,14706,573010,266011,83507,54707,31306,75806,48806,55306,28506,12805,50405,50608,63906,03100-17,4620-15,3730-13,840
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
276,264
0
278,836
0
286,135
0
286,477
0
286,458
0
286,376
286,393
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000286,393286,3760286,4580286,4770286,1350278,8360276,2640000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
249,963
236,245
271,382
254,865
272,663
255,591
248,548
257,716
262,998
257,609
261,839
259,690
262,810
259,686
263,614
260,021
264,922
262,073
266,292
262,078
266,022
262,799
267,687
263,039
267,544
264,744
269,037
264,797
253,504
286,135
257,503
286,477
13,291
286,458
13,719
13,719
286,376
286,396
280,006
286,888
288,391
272,752
272,804
272,278
256,057
256,047
326,812
327,853
329,018
327,643
328,408
328,408327,643329,018327,853326,812256,047256,057272,278272,804272,752288,391286,888280,006286,396286,37613,71913,719286,45813,291286,477257,503286,135253,504264,797269,037264,744267,544263,039267,687262,799266,022262,078266,292262,073264,922260,021263,614259,686262,810259,690261,839257,609262,998257,716248,548255,591272,663254,865271,382236,245249,963



Balance Sheet

Currency in CHF. All numbers in thousands.




Cash Flow

Currency in CHF. All numbers in thousands.




Income Statement

Currency in CHF. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,052
Cost of Revenue--
Gross Profit-2,052
 
Operating Income (+$)
Gross Profit-
Operating Expense-13,149
Operating Income-11,097-13,149
 
Operating Expense (+$)
Research Development8,037
Selling General Administrative5,261
Selling And Marketing Expenses-
Operating Expense13,14913,298
 
Net Interest Income (+$)
Interest Income76
Interest Expense-21
Other Finance Cost-0
Net Interest Income55
 
Pretax Income (+$)
Operating Income-11,097
Net Interest Income55
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-11,351-10,789
EBIT - interestExpense = -21
-11,351
-11,330
Interest Expense21
Earnings Before Interest and Taxes (EBIT)--11,330
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-11,351
Tax Provision-0
Net Income From Continuing Ops-11,351-11,351
Net Income-11,351
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-309-55
 

Technical Analysis of Addex Therapeutics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Addex Therapeutics Ltd. The general trend of Addex Therapeutics Ltd is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Addex Therapeutics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Addex Therapeutics Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 13.40 < 13.40 < 13.40.

The bearish price targets are: 11.78 > 8.998 > 8.73.

Tweet this
Addex Therapeutics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Addex Therapeutics Ltd. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Addex Therapeutics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Addex Therapeutics Ltd. The current macd is 0.60899849.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Addex Therapeutics Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Addex Therapeutics Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Addex Therapeutics Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Addex Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAddex Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Addex Therapeutics Ltd. The current adx is 31.45.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Addex Therapeutics Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Addex Therapeutics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Addex Therapeutics Ltd. The current sar is 10.65.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Addex Therapeutics Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Addex Therapeutics Ltd. The current rsi is 63.15. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Addex Therapeutics Ltd Daily Relative Strength Index (RSI) ChartAddex Therapeutics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Addex Therapeutics Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Addex Therapeutics Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Addex Therapeutics Ltd Daily Stochastic Oscillator ChartAddex Therapeutics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Addex Therapeutics Ltd. The current cci is 88.34.

Addex Therapeutics Ltd Daily Commodity Channel Index (CCI) ChartAddex Therapeutics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Addex Therapeutics Ltd. The current cmo is 32.94.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Addex Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) ChartAddex Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Addex Therapeutics Ltd. The current willr is -12.23499081.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Addex Therapeutics Ltd Daily Williams %R ChartAddex Therapeutics Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Addex Therapeutics Ltd.

Addex Therapeutics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Addex Therapeutics Ltd. The current atr is 0.82853142.

Addex Therapeutics Ltd Daily Average True Range (ATR) ChartAddex Therapeutics Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Addex Therapeutics Ltd. The current obv is 9,001,265.

Addex Therapeutics Ltd Daily On-Balance Volume (OBV) ChartAddex Therapeutics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Addex Therapeutics Ltd. The current mfi is 75.87.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Addex Therapeutics Ltd Daily Money Flow Index (MFI) ChartAddex Therapeutics Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Addex Therapeutics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Addex Therapeutics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Addex Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.145
Ma 20Greater thanMa 5011.081
Ma 50Greater thanMa 10010.389
Ma 100Greater thanMa 2008.166
OpenGreater thanClose12.350
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Addex Therapeutics Ltd with someone you think should read this too:
  • Are you bullish or bearish on Addex Therapeutics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Addex Therapeutics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Addex Therapeutics Ltd

I send you an email if I find something interesting about Addex Therapeutics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Addex Therapeutics Ltd.

Receive notifications about Addex Therapeutics Ltd in your mailbox!